drugset
drugset / Trial / NCT05701501

Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD

NCT05701501 ↗

Unknown 100 enrolled Changhai Hospital The University of Science and Technology of China · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with IBD are randomized to oral administration of vitamin B5 and placebo based on the standard treatment, exploring whether Vitamin B5 can increase the clinical remission rate of IBD patients and improve the treatment effect.

Timeline

Start
2023-02-01
Primary completion
2024-02-01
Completion
2024-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin B5 Unknown 20 mg Oral

Indications

inflammatory bowel disease